Efficacy of Majoon Ushba and topical application of Marham Raal in Quba (Tinea Corporis) – A Randomized Standard Controlled Study
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 42
- 试验地点
- 1
- 主要终点
- 1.In the present study, the efficacy of the treatment will be determined by decrease in grades from higher to lower i.e. from grade 3 to grade 2, grade 2 to grade 1, grade 1 to grade 0 with each parameter. Grade 0 is the highest level of cure that can be attained by the patient.
研究概览
简要总结
Superficialdermatophytosis of the skin in the form of Tinea corporis *(*Quba) is a very common infection seen in clinical practice. According to aWorld Health Organization survey on the prevalence of dermatophyte infection itwas found that 20% of people presenting for clinical advice are suffering fromcutaneous fungal infections worldwide.Despite the increasing prevalence of cutaneous dermatophytosisacross the world, and especially in tropics, research in this area has oftenbeen neglected.
UnaniMedicine lacks evidence based anti fungal therapy for dermatophytosis. Althoughthere are formulations which are indicated and tested by for centuries. On thebasis of these incidence, treatment failure (especially in chronic infection)and decreased quality of life due to infection, it is need of hours to conducta trial based on Unani Medicine. Hence, in order to validate and provide effectivemanagement of Quba (**Tinea Corporis), the present study entitled “Efficacy of MajoonUshba and topical application of MarhamRaal in Quba (Tinea Corporis) – A Randomized Standard Controlled Study†has been designed
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 10.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Clinically diagnosed patients of Quba (confirmed on Direct Microscopy).
- •2.Patients who have agreed to sign the informed consent form and follow the protocol.
排除标准
- •1.Patients below and above the age of 10 and 60 years respectively.
- •2.Patient suffering from concomitant diseases like psoriasis & Eczema.
- •3.Patient suffering from severe systemic and metabolic diseases.
- •4.Diabetic and HIV patient.
- •5.Pregnant & Lactating Women.
结局指标
主要结局
1.In the present study, the efficacy of the treatment will be determined by decrease in grades from higher to lower i.e. from grade 3 to grade 2, grade 2 to grade 1, grade 1 to grade 0 with each parameter. Grade 0 is the highest level of cure that can be attained by the patient.
时间窗: Baseline or 0 day 10th day, 20th day, 30th day and 40th day of the study
2.The total score includes the scores of colour of the lesion, scaling of the lesion, itching, and margins of the lesion, size of the lesion and KOH mount.
时间窗: Baseline or 0 day 10th day, 20th day, 30th day and 40th day of the study
次要结局
- 1.Negative KOH Microscopy(2.Dermatology Life Quality Index (DLQI))